Physician

Jim C Kim, MD

According to 2025 Medicare claims, Jim Kim, MD (NPI: 1992762769) practices rheumatology in the Bakersfield-Delano, CA market, with the plurality of this provider's patient population coming from Kern, CA. This provider's primary affiliated billing organization is JIM C. KIM, M.D., INC (NPI: 1841352663; TIN: 020772004) and primary practice location at 93301-3634. Kim is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Kim's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 756 traditional Medicare patients, billed 158,918 HCPCS/CPT codes, and received $2,364,819 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,660 prescription claims across 846 beneficiaries totaling $4,370,603 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 115 records totaling $3,385. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $2,140,513 to $4,370,603. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	632	149,392	$1,635,165
2016	639	135,818	$1,699,142
2017	658	138,590	$1,880,656
2018	686	133,839	$1,853,068
2019	683	137,223	$1,994,080
2020	702	130,144	$2,275,609
2021	775	161,130	$2,547,377
2022	746	175,539	$2,317,417
2023	719	162,423	$2,161,238
2024	756	158,918	$2,364,819

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	654	6,564	$2,140,513
2016	683	6,708	$2,381,003
2017	643	4,865	$2,316,614
2018	655	5,176	$2,508,089
2019	674	4,178	$1,782,772
2020	711	4,955	$2,670,132
2021	804	6,213	$3,186,502
2022	850	6,897	$3,663,817
2023	782	5,737	$3,217,207
2024	846	7,660	$4,370,603

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	275	641	$102
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	162	162	$89
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	332	581	$73
99442	Telephone medical discussion with physician, 11-20 minutes	377	958	$72
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	585	1,496	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	205	5,816	$1,476,492
Enbrel Sureclick	Etanercept	126	3,528	$900,975
Cosentyx Sensoready (2 Pens)	Secukinumab	38	1,127	$311,081
Skyrizi Pen	Risankizumab-Rzaa	13	924	$261,982
Enbrel	Etanercept	29	924	$232,380

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	115	$3,385	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jim C. Kim, MD?

Tedicare shows public-source Medicare data for Jim C. Kim, MD (NPI 1992762769), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jim C. Kim, MD have ACO affiliation data?

Jim C. Kim, MD is shown with ACO affiliation data for Collaborative ACO 30, LLC (MSSP, ACO ID A5483).

What billing organization is linked to Jim C. Kim, MD?

Jim C. Kim, MD is linked to JIM C. KIM, M.D., INC (billing NPI 1841352663) in the available physician profile data.

Does Jim C. Kim, MD have Open Payments data?

Jim C. Kim, MD has 115 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.